OBJECTIVE
In selected patients with severe end-stage combined cardiopulmonary diseases, heart-lung transplantation (HLTx) remains the only therapeutical option for improving survival and quality of life.
METHODS
Since 1983, 51 HLTx were done at our institution. Mean patient age was 27+/-12 years